Online Exclusives
-
Clinical Trials
Impact of COVID-19 on Winning New Business
Wuxi Clinical’s Vice President of Biometrics, David Ng, talks about the impact of COVID-19 on clinical trials and business relationsTim Wright, Editor, Contract Pharma 06.03.20
-
Packaging & Tracking
Contract Packaging Demand Amid COVID-19
Nic Hunt of Jones Healthcare Group discusses the pharmaceutical industry’s changing needs.Kristin Brooks, Contract Pharma 05.28.20
-
APIs | cGMP Manufacture | Clinical Trials | Supply Chain
Evaluating Pharma Amid COVID-19
Dr. Ural of Ernst & Young LLP discusses market dynamics, enduring therapeutic areas, near term M&A, and how industry can use this time for transformationKristin Brooks, Contract Pharma 05.18.20
-
Clinical Trials
Pioneering Medicine Forward
May 20th marks Clinical Trials Day, celebrating 273 years of clinical trialsTina Bland, Senior Consultant, KCR Trial Execution Consulting 05.18.20
-
Clinical Trials | CRO News | Drug Development | Information Technology | R&D
CRO Industry Update
Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.Kristin Brooks, Contract Pharma 04.27.20
-
Drug Development | R&D
COVID-19 and the Importance of Combating Antimicrobial Resistance
Dr. Frank of Working to Fight AMR discusses the global COVID-19 pandemic and the critical need to address the public health crisis of Antimicrobial ResistanceKristin Brooks, Contract Pharma 04.13.20
-
Clinical Trials | Information Technology | QA/QC
Managing Clinical Trials Amid the Coronavirus Pandemic
Patrick Hughes of CluePoints discusses the impact on clinical trials and how leveraging data may herald a long overdue paradigm shift in the industry.Kristin Brooks, Contract Pharma 04.06.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trials | Drug Development | Scale-up/Technology Transfer
Rapid Delivery of Medical Countermeasures Amid Pandemic
Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccinesKristin Brooks, Contract Pharma 04.03.20
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
COVID-19 Vaccine Response
ICON execs discuss developments in vaccine research efforts and key challenges of delivering a coronavirus vaccineKristin Brooks, Contract Pharma 04.01.20
-
cGMP Manufacture | Drug Development | Logistics | Supply Chain
COVID-19: Business Update
Thermo Fisher Scientific provides perspective on the COVID-19 pandemic and how the company is working to help minimize disruptionsKristin Brooks, Contract Pharma 03.30.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Drug Development
Newsmakers: Thermo Fisher Scientific
Leon Wyszkowski discusses the company’s recent investments, the challenges biopharma companies face, and future needs in the outsourcing space03.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development
COVID-19 Clinical Trials
The vaccines in development for COVID-19, who's developing them, and where they stand in the development processKristin Brooks, Contract Pharma 03.10.20
-
APIs | Breaking News | Supply Chain
API Supply for U.S. Market
A breakdown of manufacturing facilities making active pharmaceutical ingredients (APIs) for U.S. marketKristin Brooks, Contract Pharma 03.05.20
-
Clinical Trials | Drug Development | R&D
Rare Disease R&D
Finding the hard-to-reach and leveraging big data and machine learning in drug developmentKristin Brooks, Contract Pharma 02.25.20
-
Drug Development
Major Drug Approvals of 2019
Abbvie, Novartis, Pfizer and J&J score big wins with blockbuster potentialKristin Brooks, Contract Pharma 02.24.20
-
Bio News | Biologics, Proteins, Vaccines | cGMP Manufacture
Newsmakers: Vigene Biosciences
Dr. Jeffrey Hung, Chief Commercial Officer, discusses Vigene’s new $20 million lab and strategic partnership with ASC TherapeuticsKristin Brooks, Contract Pharma 02.20.20
-
cGMP Manufacture | Information Technology | Scale-up/Technology Transfer
The Future of Pharmaceutical Manufacturing
Neo PLM’s Cathal Strain discusses the need for a digital revolution to drive manufacturing innovationKristin Brooks, Contract Pharma 02.12.20
-
Facilities
CEO Spotlight: Vincent Dunne
Wasdell Group's chief executive talks trends and plans for continued growthTim Wright, Contract Pharma 02.10.20
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Industry News
Outsourcing in the Cell & Gene Therapy Space
Specialized and coordinated capabilities aim to accelerate drug development and reduce risk for sponsorsKristin Brooks, Contract Pharma 02.04.20
-
cGMP Manufacture | Cytotoxics and High Potency Manufacturing
HPAPI Market Trends: PCI Expands Capabilities
Michael Ellingson of PCI discusses market demand for specialty drug product capabilities and the Rockford, IL expansionKristin Brooks, Cotract Pharma 01.10.20
